P087: Increased wnt ligands expression in M2c macrophages is associated with fibrosis in Stat6 knockout miceECCO '17 Barcelona
2017
P088: Evaluation of Free Vitamin D levels in IBD pediatric patients: the role of inflammationECCO '17 Barcelona
2017
P089: Extracellular matrix fragments as markers of cytokine driven intestinal damage or protection; test in a novel intestinal ex vivo modelECCO '17 Barcelona
2017
P090: Metformin induces late Apoptosis and modulates dysbiosis in western-style diet induced colitic cancerECCO '17 Barcelona
2017
P091: Usefulness of transcriptional whole blood biomarkers as a non-invasive surrogate marker of mucosal healing and endoscopic response in ulcerative colitisECCO '17 Barcelona
2017
P092: Exogenous administration of IL-4-treated macrophages prevents intestinal fibrosis in Stat6 knockout miceECCO '17 Barcelona
2017
P093: Dysregulation of cellular vs humoral immunity to the intestinal microbiota in inflammatory bowel diseaseECCO '17 Barcelona
2017
P094: DNA methylation patterns in Crohn's disease mucosal-derived fibroblastsECCO '17 Barcelona
2017
P095: The genetic risk in ER stress and autophagy translates into quantifiable epithelial ER stress levels in IBD patientsECCO '17 Barcelona
2017
P096: Combined detection variants of NUDT15 could highly predict thiopurine-induced leukopenia in Chinese patients with inflammatory bowel disease: a multi-center analysisECCO '17 Barcelona
2017
P097: Th2 cytokines are potent stimulators of pro-fibrotic responses by human intestinal subepithelial myofibroblastsECCO '17 Barcelona
2017
P098: Oregonin inhibits intestinal epithelial injury by modulating heme oxygenase-1ECCO '17 Barcelona
2017
P100: Intestinal epithelial cells under endoplasmic reticulum stress boosts serine proteolytic activity and modulates barrier functionECCO '17 Barcelona
2017
P102: Hypoxia reduces inflammation through the downregulation of NLRP3/mTOR signaling and the activation of autophagyECCO '17 Barcelona
2017
P103: Evaluation of efficacy of new vectors for siRNA CYCLIN D1 and E2F1 delivery in control of cancer progression in inflammatory bowel diseaseECCO '17 Barcelona
2017